Douglas A Treco

CRSP

Douglas A Treco serves as Director at CRISPR Therapeutics AG (CRSP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.14M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$1.14M

Companies Traded

CRSP

Active Period

Aug 2025

1 total trades

Most Recent

Buy CRSP

Aug 6, 2025 · $1.14M

Douglas A Treco's Insider Trading at CRISPR Therapeutics AG (CRSP)

Buys

1 · $1.14M

Sells

0 · $0.00

Total Shares Bought

20,000

Total Shares Sold

CRSP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 6, 2025↗	Buy	20,000	$57.03	$1.14M	0

Related Insiders

KASINGER JAMES R.

General Counsel and Secretary

CRSPSell · Feb 19, 2026

Samarth Kulkarni

Chief Executive Officer

CRSPSell · Feb 19, 2026

Raju Prasad

Chief Financial Officer

CRSPSell · Jan 22, 2026

Simeon George

Director

CRSPBuy · Jul 16, 2025

Naimish Patel

Chief Medical Officer

CRSPSell · May 29, 2025

Julianne Bruno

Chief Operating Officer

CRSPSell · Mar 21, 2025

Explore More Insider Trading Data

CRSP Insider Trading Activity

View all insider trades at CRISPR Therapeutics AG

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity